Search the Newsreel

Standard Motor Products: Q2 Earnings Snapshot

Banco Santander (BME:SAN) Wins Webster Approval, Is The Stock Fully Valued?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Regulatory approval for Webster deal puts Banco Santander in focus Banco Santander (BME:SAN) is back on investors' radar after securing US Federal Reserve approval …

Santander, Berkshire Hathaway among gainers; HSBC, Sezzle in losers: week's financials wrap

[Old Fashioned Bank Sign] georgeclerk/E+ via Getty Images Wall Street finished the week higher [https://seekingalpha.com/article/4933719-what-moved-markets-this-week], with the benchmark S&P 500 hitting fresh all-time highs as investors digested key earnings from technology giants alongside the latest payrolls data. A sharp contraction in the U.S. labor …

Banco Santander Nears Completion of Multi-Billion-Euro Share Buyback

Banco Santander is nearing the completion of a substantial share buyback program, having repurchased approximately €4.39 billion worth of shares, representing 87.3% of the planned maximum investment. Since 2021, the bank has bought back around 17.7% of its outstanding shares, aiming to reduce share …

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss?

StandardAero, Inc. Q2 2026: Revenue $1599.7M, EPS $0.29— 10-Q Summary

StandardAero, Inc. (SARO) reported strong second-quarter 2026 results, with revenue reaching $1599.7 million and net income climbing to $97.3 million, significantly up from the previous year. Diluted EPS also increased to $0.29. The company's growth was fueled by commercial aerospace and business aviation demand, …

Arrowstreet Capital Limited Partnership Sells 399,712 Shares of Banco Santander Chile $BSAC

Wall Street Zen Downgrades Standard Motor Products (NYSE:SMP) to Hold

Notícias das Ações da Banco Santander-Chile (BSAC)

Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight

Tandem Diabetes Care's stock surged 19% after its Q2 earnings report, despite a net loss, due to a significant recovery in gross margin to 57%. Revenue grew 6%, and the net loss narrowed by 60%, with strong performance in international pump shipments and an …

Standard Engineering Technology Ltd (NSE:SETL) (Q1 2027) Earnings Call Highlights: Record ...

Noticias de acciones de Banco Santander SA (SAN)

Standex (SXI) Q4 2026 Earnings Call Transcript

Standex (SXI) reported record Q4 2026 earnings, with net sales growing 7.7% organically to $228.3 million and adjusted EPS reaching $2.45. The company is strategically focusing on expanding its grid business capacity, aiming for $340 million to $440 million in annual sales by fiscal …

Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside

Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …

Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS

Standex International (SXI) Is Up 14.7% After Strong FY 2026 Earnings And 2027 Growth Outlook

SANB11: Upcoming Governance Shakeup Will Support Bullish Long-Term Outlook

Banco Santander (Brasil) (SANB11) has seen its analyst price target adjusted to R$34.43, reflecting updated assumptions for revenue, profit margins, and P/E multiple. The company is undergoing significant governance changes, including a proposed acquisition by Banco Santander, S.A., a CEO transition, and an upcoming …

Banco Santander (BME:SAN) Stock May Be 31% Undervalued On Fed Deal Approval

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Banco Santander has delivered very strong gains for shareholders over the last five years, …

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …

Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates

Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …

Standex International Corp (SXI) Shares Surge 3.4% -- What GF Sc

Standex International Corp (SXI) shares rose 3.4% to $337.63. GuruFocus indicates the stock is significantly overvalued by 53.1% based on its GF Value™ estimate of $220.55. The company has a GF Score™ of 68/100, showing strong profitability but lower growth and valuation ranks, and …

Santander Gets Fed Approval for Webster Acquisition

Santander has received approval from the Federal Reserve for its acquisition of Webster Financial Corporation, following earlier approvals from the OCC and ECB. The transaction is expected to close on August 20, 2026, and will merge Webster's operations into Santander Bank, N.A., aiming to …

StandardAero (NYSE: SARO) clarifies Q2 $72.3M operating cash flow

StandardAero, Inc. (NYSE: SARO) has issued an amendment to correct its description of second-quarter 2026 cash flow from operations. The company clarified that it generated $72.3 million in cash from operations for the three months ended June 30, 2026, rather than using cash as …

Standard BioTools Inc (LAB) Stock News Today

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM) 2026-08-07

Tandem Diabetes Care Q2 Earnings Call Highlights

Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - What's Next?

Tandem Diabetes Care (NASDAQ:TNDM) shares gapped down but later rose by 13.8%. Analyst ratings are mixed, with a consensus "Hold" and an average price target of $28.77, though Mizuho lowered its target to $20. The company reported an adjusted loss of $0.31 per share, …

Banco Santander Brasil (NYSE:BSBR) Sees Strong Trading Volume - Time to Buy?

Tandem Diabetes Care seeing early benefits of new pay-as-you-go model

Notícias das Ações da Banco Santander SA (SAN)

Banco Santander Brasil SA (BSBR) Stock News Today

Banco Santander Brasil SA Stock 12‑Month Price Target Cut to $6.7, Implies 16% Upside

Analysts have lowered the average 12-month price target for Banco Santander Brasil SA (SANB3) stock from $6.85 to $6.7, with individual forecasts ranging from $5.26 to $8.61 per share. This updated target suggests a potential upside of approximately 16% based on the August 6 …

Dimensional Fund Advisors LP Raises Stock Position in Banco Santander Chile $BSAC

StandardAero (SARO) boosts profit as 2026 revenue hits $3.23B and debt tops $2.35B

Standard BioTools (LAB) Stock Rebound Leaves Revenue Slide And Losses In Focus

Standard BioTools (LAB) saw a slight stock rebound after its Q2 2026 earnings, but this is overshadowed by a 7.6% revenue decline to US$20.1 million and persistent losses, despite a narrower net loss from continuing operations. The market is waiting for sustained top-line growth …